Trials / Completed
CompletedNCT00434681
Paracetamol Oral Paediatric Suspension at 4.8% : Study of Acceptability and Safety.
Multicentre, Open, Non-Comparative Study of the Acceptability and Safety of Paracetamol Oral Paediatric Suspension at 4.8%.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 48 (planned)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 1 Day – 8 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate the acceptability over 24 hours of a new paracetamol formulation 4.8% paediatric oral suspension in children weighing between 3 and 26 kg including limits
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | paracetamol 4.8% paediatric oral suspension |
Timeline
- Start date
- 2006-10-01
- Completion
- 2007-04-01
- First posted
- 2007-02-13
- Last updated
- 2008-07-21
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00434681. Inclusion in this directory is not an endorsement.